Equfina is indicated for the treatment of adult patients with idiopathic Parkinson's disease (PD) as add-on therapy to a stable dose of levodopa (L-dopa) alone or in combination with other PD medicinal products in mid- to late-stage fluctuating patients.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
